Business Context and Reporting Period
Company: Church & Dwight Co., Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2009
Business Overview: The Company develops, manufactures, and markets household, personal care, and specialty products under eight "power brands," including ARM & HAMMER, TROJAN, XTRA, OXICLEAN, NAIR, FIRST RESPONSE, ORAJEL, and SPINBRUSH. Operations are divided into three segments: Consumer Domestic (74% of sales), Consumer International (16%), and Specialty Products (10%).
Key Financial Metrics
| Metric | 2009 | 2008 |
|---|---|---|
| Net Sales | $2,520.9 million | $2,422.4 million |
| Gross Profit | $1,101.0 million | $971.7 million |
| Gross Margin | 43.7% | 40.1% |
| Income from Operations | $412.9 million | $340.3 million |
| Net Income (Attributable to C&D) | $243.5 million | $195.2 million |
| Diluted EPS | $3.41 | $2.78 |
| Operating Cash Flow | $400.9 million | $336.2 million |
| Total Debt | $816.3 million | $856.1 million |
| Cash and Equivalents | $447.1 million | $198.0 million |
| Net Debt | $369.2 million | $658.1 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 4% ($98.5 million) driven by higher prices (approx. 3%), improved sales mix, and higher volumes (approx. 2%). This was partially offset by a 2% reduction due to foreign exchange rates and the divestiture of non-core product lines.
- Margin Expansion: Gross margin improved by 360 basis points to 43.7%, reflecting lower commodity costs, price increases instituted in 2008, and cost reduction programs.
- Profitability: Net income increased 25% to $243.5 million. This was significantly boosted by a $20.0 million pre-tax gain from the settlement of patent litigation with Abbott Laboratories.
- Segment Performance:
- Consumer Domestic: Sales up 9.6% and income before taxes up 37.4% (including the Abbott gain).
- Consumer International: Sales down 6.3% due to unfavorable foreign exchange (approx. 10% impact) and the divestiture of a Spanish subsidiary.
- Specialty Products: Sales down 14.0% due to lower volumes in animal nutrition (linked to lower U.S. milk prices) and the prior-year sale of a UK subsidiary.
- Capital Structure: Total debt decreased by $39.8 million, while cash increased by $249.1 million, significantly reducing net debt.
Guidance, Outlook, and Risks
- Facility Transition: Completed construction of a new integrated laundry detergent plant in York, Pennsylvania, and closed the North Brunswick, New Jersey facility. This transition involved shutdown charges of approximately $25.5 million pre-tax.
- Dividend: The Board increased the quarterly dividend from $0.09 to $0.14 per share in July 2009.
- Pension Plan Termination: The Board approved the termination of the domestic defined benefit pension plan, effective April 15, 2010. The Company estimates a one-time expense of $20 million to $23 million upon settlement.
- Key Risks:
- Economic Conditions: Recessionary pressures may lead to increased price competition and consumer spending cuts on discretionary items.
- Customer Concentration: Wal-Mart accounts for approximately 22% of total consolidated net sales.
- Raw Material Costs: Volatility in surfactants, palm oil, and energy prices could erode margins if not passed to customers.
- Regulatory: Potential FDA restrictions on the spermicide N-9 in TROJAN condoms could impact sales.
Investor Verification Checklist
- Abbott Settlement: Verify the sustainability of earnings excluding the $20 million one-time litigation gain.
- York Facility ROI: Monitor the efficiency gains and cost savings from the new York, PA plant versus the shutdown costs of North Brunswick.
- Pension Termination Costs: Track the actual cash contributions and one-time expense incurred for the domestic pension plan termination in 2010.
- Wal-Mart Dependency: Assess the impact of any changes in trade terms or shelf space allocation from Wal-Mart, the largest customer.
- Commodity Hedging: Review the effectiveness of hedging strategies against diesel fuel and raw material price fluctuations.